(Nanowerk Spotlight) Biosensors, which incorporate biological probes coupled to a transducer, have been developed during the last two decades for environmental, industrial, and biomedical diagnostics.

Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology--a ...

DNA can signal the presence of or predisposition to a slew of diseases, including cancer. The ability to flag down these clues, known as biomarkers, allows medical professionals to make critical early ...

Some mutations in the DNA are harmless, and a person could go their entire life with the mutation and never know. Other mutations cause a myriad of health problems: cancer, diabetes, heart disease, ...

Fusobacterium nucleatum, a bacterium linked to colorectal cancer, possesses a specific gene called fadA that serves as an early diagnostic biomarker. The CRISPR/Cas12a system has demonstrated marked ...

Scientists have developed a new fluorescent biosensor that could aid in the development of an important class of drugs that target a crucial class of proteins called G protein-coupled receptors (GPCRs ...

A new biosensor chip that boasts an accurate and inexpensive design may increase accessibility to high-quality diagnostics. The biosensor, developed by researchers at the National Institute of ...

Medical biotechnology diagnostics has undergone transformative evolution through the integration of molecular recognition elements with advanced sensor technologies. Contemporary platforms now merge ...

Optical biosensors and micromotors that can sense and actuate biological environments are considered promising theranostic devices because of their high spatial resolution and flexibility. Advancing ...

One of the most common indicators of many diseases and cancer in blood is the presence of a genetic mutation known as a single nucleotide polymorphism (SNP). Unfortunately, to date such tests for SNPs ...